September 17, 2019
ViiV Healthcare has filed a new drug application (NDA) in Japan for its fixed-dos anti-HIV treatment combination drug containing dolutegravir and lamivudine for treatment-naïve adult patients with HIV-1 infection, it said on September 13. The drug, known as Dovato, is...read more